Cefazolin vs. cloxacillin in MSSA endocarditis: too good to be true? Authors ’ reply

We sincerely appreciate the comments of DTP Buis and his interest for our work, and we would like to response to his justified concerns [1,2]:

Source: International Journal of Infectious Diseases - February 21, 2024 Category: Infectious Diseases Authors: Laura Herrera-Hidalgo, Ar ístides de Alarcón Tags: Letter to the Editor Source Type: research